Page 1140 - Hematology_ Basic Principles and Practice ( PDFDrive )

1004.e2 Part XII Hemostasis and Thrombosis

tissues: report of the Clinical Advisory Committee meeting-Airlie 70. Greenberg P, Taylor K, Larson R, et al: Phase III randomized multi-
House, Virginia, November 1997. J Clin Oncol 17:3835, 1999. center trial of G-CSF vs. observation for MDS. Blood 82:196a, 1993.
49. Vardiman JW, Thiele J, Arber DA, et al: The 2008 revision of the 71. Hellstrom-Lindberg E: Efficacy of erythropoietin in the myelodysplas-
World Health organization (WHO) classification of myeloid neoplasms tic syndromes: a meta-analysis of 205 patients from 17 studies. Br J
and acute leukemia: rationale and important changes. Blood 114:937, Haematol 89:67, 1995.
2009. 72. Negrin RS, Stein R, Vardiman J, et al: Treatment of the anemia of
50. Baumann I, Niemeyer CM, Bennett J: Childhood myelodysplastic myelodysplastic syndromes using recombinant human granulocyte
syndrome. In Swerdlow S, Campo E, Harris N, et al, editors: WHO colony-stimulating factor in combination with erythropoietin [see
classification of tumours of haematopoietic and lymphoid tissues, Lyon, comments]. Blood 82:737, 1993.
2008, IARC Press, p 104. 73. Negrin RS, Stein R, Doherty K, et al: Maintenance treatment of
51. Arber DA, Orzi A, Hasserjian R, et al: The 2016 revision of the World the anemia of myelodysplastic syndromes with recombinant human
Health Organization classification of myeloid neoplasms and acute granulocyte colony-stimulating factor and erythropoietin: evidence for
leukemia. Blood 127:2391, 2016. in vivo synergy. Blood 87:4076, 1996.
52. Hasle H, Niemeyer CM, Chessells JM, et al: A pediatric approach 74. Sandor V, Bakke S, Robey RW, et al: Phase I trial of the histone
to the WHO classification of myelodysplastic and myeloproliferative deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in
diseases. Leukemia 17:277, 2003. patients with refractory neoplasms. Clin Cancer Res 8:718, 2002.
53. Kardos G, Baumann I, Passmore SJ, et al: Refractory anemia in child- 75. Marshall JL, Rizvi N, Kauh J, et al: A phase I trial of depsipeptide
hood: a retrospective analysis of 67 patients with particular reference (FR901228) in patients with advanced cancer. J Exp Ther Oncol 2:325,
to monosomy 7. Blood 102:1997, 2003. 2002.
54. Ramos F, Fernandez-Ferrero S, Suarez D, et al: Myelodysplastic syn- 76. Bejar R, Steensma DP: Recent developments in myelodysplastic syn-
drome: a search for minimal diagnostic criteria. Leuk Res 23:283, 1999. dromes. Blood 124:2793, 2014.
55. Dunn DE, Tanawattanacharoen P, Boccuni P, et al: Paroxysmal 77. Mathew P, Gerbing R, Alonzo TA, et al: A phase II study of amifostine
nocturnal hemoglobinuria cells in patients with bone marrow failure in children with myelodysplastic syndrome: a report from the Children’s
syndromes [see comments]. Ann Intern Med 131:401, 1999. Oncology Group study (AAML0121). Pediatr Blood Cancer 57:1230,
56. Aalbers AM, van den Heuvel-Eibrink MM, Baumann I, et al: Bone 2011.
marrow immunophenotyping by flow cytometery in refractory cytope- 78. Cseh AM, Niemeyer CM, Yoshimi A, et al: Therapy with low-dose
nia of childhood. Haematologica 100:315, 2014. azacytidine for MDS in children and young adults: a retrospective
57. Elmahdi S, Hama A, Manabe A, et al: A cytokine-based diagnostic analysis of the EWOG-MDS study group. Br J Haematol 172:930,
program in pediatric aplastic anemia and hypocellular refractory 2016.
cytopenia of childhood. Pediatr Blood Cancer 63:652, 2016. 79. Waespe N, Van Den Akker M, Klaassen RJ, et al: Response to treatment
58. Webb DK, Passmore SJ, Hann IM, et al: Results of treatment of with azacitidine in children with advanced myelodysplastic syndrome
children with refractory anaemia with excess blasts (RAEB) and RAEB prior to hematopoietic stem cell transplantation. Haematologica, epub
in transformation (RAEBt) in Great Britain 1990-1999. Br J Haematol ahead of print, 2016.
117:33, 2002. 80. Strahm B, Locatelli F, Bader P: Reduced intensity conditioning in
59. Woods WG, Barnard DR, Alonzo TA, et al: Prospective study of 90 unrelated donor transplantation for refractory cytopenia in childhood.
children requiring treatment for juvenile myelomonocytic leukemia or Bone Marrow Transplant 40:329, 2007.
myelodysplastic syndrome: a report from the Children’s Cancer Group. 81. Yusuf U, Frangoul HA, Gooley TA, et al: Allogeneic bone marrow
J Clin Oncol 20:434, 2002. transplantation in children with myelodysplastic syndrome or juvenile
60. Bagby GC, Jr, Gabourel JD, Linman JW: Glucocorticoid therapy in myelomonocytic leukemia: the Seattle experience. Bone Marrow Trans-
the preleukemic syndrome (hemopoietic dysplasia): identification of plant 33:805, 2004.
responsive patients using in-vitro techniques. Ann Intern Med 92:55, 82. Trobaugh-Lotrario AD, Kletzel M, Quinones RR, et al: Monosomy 7
1980. associated with pediatric acute myeloid leukemia (AML) and myelo-
61. Hurtado R, Sosa R, Majluf A, et al: Refractory anaemia (RA) type dysplastic syndrome (MDS): successful management by allogeneic
I FAB treated with oxymetholone (OXY): long-term results [letter; hematopoietic stem cell transplant (HSCT). Bone Marrow Transplant
comment]. Br J Haematol 85:235, 1993. 35:143, 2005.
62. Najean Y, Pecking A: Refractory anemia with excess of blast cells: 83. Kalwak K, Wojcik D, Gorczynska E, et al: Allogeneic hematopoietic
prognostic factors and effect of treatment with androgens or cytosine cell transplantation from alternative donors in children with myelo-
arabinoside. Results of a prospective trial in 58 patients. Coopera- dysplastic syndrome: Is that an alternative? Transplant Proc 36:1574,
tive Group for the Study of Aplastic and Refractory Anemias. Cancer 2004.
44:1976, 1979. 84. Woodard P, Carpenter PA, Davies SM, et al: Unrelated donor bone
63. Cines DB, Cassileth PA, Kiss JE: Danazol therapy in myelodysplasia. marrow transplantation for myelodysplastic syndrome in children. Biol
Ann Intern Med 103:58, 1985. Blood Marrow Transplant 17:723, 2011.
64. Letendre L, Levitt R, Pierre RV, et al: Myelodysplastic syndrome treat- 85. Strahm B, Nollke P, Zecca M, et al: Hematopoietic stem cell transplan-
ment with danazol and cis-retinoic acid. Am J Hematol 48:233, 1995. tation for advanced myelodysplastic syndrome in children: results of the
65. Koeffler HP, Heitjan D, Mertelsmann R, et al: Randomized study of EWOG-MDS 98 study. Leukemia 25:455, 2011.
13-cis retinoic acid v placebo in the myelodysplastic disorders. Blood 86. Yoshimi A, Strahm B, Baumann I, et al: Hematopoietic stem cell trans-
71:703, 1988. plantation in children and young adults with secondary myelodysplastic
66. Clark RE, Ismail SA, Jacobs A, et al: A randomized trial of 13-cis syndrome and acute myelogenous leukemia after aplastic anemia. Biol
retinoic acid with or without cytosine arabinoside in patients with the Blood Marrow Transplant 20:421, 2014.
myelodysplastic syndrome. Br J Haematol 66:77, 1987. 87. Kato M, Yoshida N, Inagaki J, et al: Salvage allogeneic stem cell
67. Kurzrock R, Estey E, Talpaz M: All-trans retinoic acid: tolerance and transplantation in patients with pediatric myelodysplastic syndrome
biologic effects in myelodysplastic syndrome. J Clin Oncol 11:1489, ad myeloproliferative neoplasms. Pediatr Blood Cancer 61:1860, 2014.
1993. 88. Woehlecke C, Wittig S, Arndt C, et al: Prognostic impact of WT1
68. Ohno R, Naoe T, Hirano M, et al: Treatment of myelodysplastic expression prior to hematopoietic stem cell transplantation in children
syndromes with all-trans retinoic acid. Leukemia Study Group of the with malignant hematological diseases. J Cancer Res Clin Oncol 141:523,
Ministry of Health and Welfare. Blood 81:1152, 1993. 2015.
69. Schuster MW, Larson RA, Thompson JA, et al: Granuloycte- 89. Ustun C, Trottier BJ, Sachs Z, et al: Monosomal karyotype at the
macrophage colony-stimulating factor (GM-CSF) for myelodysplastic time of diagnosis or transplantation predicts outcomes of allogeneic
syndrome (MDS): results of a multi-center randomized controlled trial. hematopoietic cell transplantation in myelodysplastic syndrome. Biol
Blood 76:318a, 1990. Blood Marrow Transplant 21:866, 2015.